Allied Market Research
Allied Market Research

Disease-Modifying Agents Market by Drug Class (Interferon Beta-1?/?, Natalizumab, Mitoxantrone, Glatiramer Acetate, Fingolimod, Dimethyl Fumarate, Ocrelizumab, Teriflunomide, Ciclosporin, Cyclophosphamide, Hydroxychloroquine, Leflunomide, Methotrexate, Mycophenolate, Sulfasalazine, and Others), Indication (Multiple Sclerosis, Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Systemic Sclerosis, Cancer, and Others), Therapy Type (Monotherapy and Combination Therapy), Route of Administration (Oral, Infusion, Subcutaneous, Intravenous), and End User (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others): Global Opportunity Analysis and Industry Forecast, 2021–2030

Pages: NA
Sep 2021 | 44 Views
Author(s) : Onkar Sumant
Tables: NA
Charts: NA
  • Formats*:

  • SIngle User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • IComes with the additional cost
    of $2500.00 contact sales.



Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Disease-modifying Agents Market

Request Now !

Disease modification can be defined as treatments that affect the underlying pathophysiology of the disease and have a beneficial outcome. In the struggle to decrease the development of disease in many inflammatory conditions such as rheumatoid arthritis, psoriasis, and psoriatic arthritis, multiple sclerosis, and Crohn's disease, the disease-modifying agent class, including treatments such as anti-TNF agents and immunomodulators, averting the progression of each disease and also the market is experiencing notable growth. However, the landscape has changed with the entry of disease-modifying agents. Several new disease-modifying drugs are in the line, all of which will offer important options for patients with these diseases, thus promoting the growth of the disease-modifying agents market.

Market Scope and Structure Analysis

Report Metric


Market Size Available for Years


 Base Year Considered


 Forecast Period


 Forecast Unit

Value (USD)

 Segments Covered

Drug class, Indication, Route of administration, Therapy type, End User, and Region

 Regions Covered

North America, Europe, Asia-Pacific, and LAMEA

 Companies Covered

Biogen Inc., Merck KGaA, Elan Pharma India Pvt Ltd., Fresenius Kabi, Pfizer Inc, Teva Pharmaceutical Industries Ltd., Hospira, Inc., Accord Healthcare Inc, Nordic Group Bv, Antares Pharma, Inc., Sanofi Aventis, Pharmascience Inc, Ascend Laboratories Ltd, Novartis International AG, Strides Pharma Science Limited,

COVID-19 Impact analysis

Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing shortage of these drugs. Thus, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future owing to the demand for vaccine and treatment drugs for COVID-19. This in turn is expected to have a significant impact on the disease-modifying agents market.

Top Impacting Factors

  • Increase in cases of inflammatory diseases, surge in geriatric population, rise in demand for minimally invasive procedure & advanced treatments such as disease modifying agents are the factors that drive the growth of the disease modifying agents market.
  • Disease-modifying anti-rheumatic agents work to suppress the body's overactive immune and/or inflammatory systems; anti-TNFs are extremely effective treatments; disease-modifying agents are also effective for osteoarthritis; however, the agents are still under the clinical trial phase. Limited availability of products is anticipated to provide a lucrative opportunity to launch disease-modifying agents in the market.
  • Few factors expected to hinder the growth of the disease modifying agents market include drug recalls by the FDA and EMA and increase in cost of multiple sclerosis disease-modifying agents.

Market Trends

Promising Product Pipeline Expected to Flourish the Market

Companies are taking efforts to develop therapeutic modalities for underlying pathophysiological changes in Alzheimer’s disease and other neurodegenerative disorders.

A phase 3 study of isradipine is being carried out as a disease-modifying agent in patients with early Parkinson's disease by STEADY-PD III, funded by National Institute of Neurological Disorders and Stroke (NINDS).

In September 2020, Prothena Corporation plc declared the results of the Phase 2 PASADENA study of prasinezumab, which is the first anti-inflammatory, anti-alpha-synuclein antibody to show efficacy in patients with early Parkinson's disease.

Key Segments Covered



 Drug Class

  • Interferon Beta-1α/β
  • Natalizumab
  • Mitoxantrone
  • Glatiramer Acetate
  • Fingolimod
  • Dimethyl Fumarate
  • Ocrelizumab
  • Teriflunomide
  • Ciclosporin
  • Cyclophosphamide
  • Hydroxychloroquine
  • Leflunomide
  • Methotrexate
  • Mycophenolate
  • Sulfasalazine
  • Others


  • Multiple Sclerosis
  • Rheumatoid Arthritis
  • Psoriatic Arthritis
  • Ankylosing Spondylitis
  • Systemic Sclerosis
  • Cancer
  • Others

 Therapy Type

  • Monotherapy
  • Combination therapy

 Route of Administration

  • Oral
  • Infusion
  • Subcutaneous
  • Intravenous

 End User

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others


  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA


Key Benefits of the Report

  • This study presents the analytical depiction of the disease-modifying agents industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the disease-modifying agents market share.
  • The current market is quantitatively analyzed from 2020 to 2030 to highlight the disease-modifying agents market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed disease-modifying agents market analysis based on competitive intensity and how the competition will take shape in coming years

Questions answered in the disease-modifying agents Report

  • Who are the leading players active in the gamete preservation market?
  • What are the current trends that will influence the market in the next few years?
  • What is "Disease-modifying agents "?
  • What is "Disease-modifying agents" Market prediction in the future?
  • Who are the leading global players in the "Disease-modifying agents" Market?                                                                                                                                                                                                         
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Start reading ,This Report and over 13000+ thousand more Reports, Available with Avenue Library, T&C*

Reach out to us

Call us on
( U.S. - Canada toll free )
Int'l : +1-503-894-6022
( Europe )
+ 44-845-528-1300
Drop us an email at

Allied Market Research Allied Market Research Allied Market Research

Access from any device, anywhere

Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.










Purchase Full Report of
Disease-Modifying Agents Market

  • Online Only
  • $3,456  $3,110
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3,840  $3,456
  • Restricted to one authorized user
  • One print only
  • Available in
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5,769  $5,192
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,450  $5,805
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise

  • $8,995  $8,096
  • Unlimited
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
  • Company Profiles
  • Newly Added Content Access
  • 10 PDF
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Start reading.
    This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.

    Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD


Why Allied Market Research?


Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers


Featured Reports


Erythropoietin Drugs Market

Global Opportunity Analysis and Industry Forecast, 2021–2028

Published in May 2021

Download Sample

Protein Therapeutics Market

Global Opportunity Analysis and Industry Forecast, 2017-2023

Published in Nov 2017

Download Sample

Surgical Equipment Market

Global Opportunity Analysis and Industry Forecast, 2020-2027

Published in Jan 2021

Download Sample

Medical Implant Market

Global Opportunity Analysis and Industry Forecast, 2020–2027

Published in Nov 2020

Download Sample

Featured Readings


Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?


Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers